Skip to main content

Table 1 Clinical, demographic and echocardiographic characteristics split by aetiology of mitral regurgitation

From: Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomes

 

All (n = 388)

ASMR (n = 37)

VSMR (n = 113)

Primary MR (n = 193)

Other MR (n = 45)

p-value

Demographics

Age (years)

75 (65–83)

82 (74–87)

76 (66–82.5)

75 (65–82)

69 (49.5–78)

 < 0.001

Female sex [n(%)]

197 (50.8)

(25 (67.6)

55 (48.7)

86 (44.6)

31 (68.9)

0.004

Past medical history

AF [n(%)]

200 (44.4)

31 (83.8)

54 (48.2)

95 (49.5)

20 (44.4)

0.001

Hypertension [n(%)]

114 (29.6)

15 (40.5)

34 (30.6)

53 (27.6)

12 (26.7)

0.43

IHD [n(%)]

138 (35.8)

16 (43.2)

66 (59.5)

51 (26.6)

5 (11.1)

 < 0.001

Diabetes [n(%)]

49 (12.7)

4 (10.8)

17 (15.3)

20 (10.4)

8 (17.8)

0.43

Stroke/TIA [n(%)]

47 (12.2)

5 (13.5)

14 (12.6)

25 (13.0)

3 (6.7)

0.69

Left ventricle

      

LVEDd (mm)

53.0 ± 9.1

48.0 ± 8.9

57.6 ± 9.0

52.1 ± 8.2

49.3 ± 1.3

 < 0.001

LVESd (mm)

38.0 ± 11.0

33.1 ± 7.6

46.8 ± 11.5

35.1 ± 8.6

32.2 ± 8.2

 < 0.001

LVEDV (ml)

136 (102.8–183)

95.5 (67.8–112.8)

158 (124–205)

136 (104–182.8)

123 (100–142)

 < 0.001

LVESV (ml)

59 (40.8–90)

36.5 (23.3–45.8)

102 (72–140)

53.5 (39–77)

52 (36–69.5)

 < 0.001

LVEF (%)

52.8 ± 15.9

62.3 ± 7.6

37.6 ± 14.9

58.7 ± 11.9

57.9 ± 11.7

 < 0.001

Left atrium

      

LA diameter (mm)

46 (41–52)

47 (42–53)

47 (41.3–50.8)

47 (41–52)

45 (41–51)

0.82

LA volume (ml)

89 (69–89)

89 (74–138)

88 (69.5–115)

90 (67–131)

92.5 (68–117.8)

0.77

Valvular dysfunction

      

MR severity 4 + [n(%)]

262 (67.5)

22 (59.5)

66 (58.4)

145 (75.1)

29 (64.4)

0.014

MA diameter A2c (cm)

34.9 ± 6.3

34.2 ± 5.5

36.3 ± 6.4

34.8 ± 6.4

32.5 ± 5.8

0.006

MA diameter A3c (cm)

32.7 ± 6.2

34.1 ± 6.5

34.2 ± 6.1

32.0 ± 5.8

31.0 ± 6.9

0.003

MA diameter A4c

35.5 ± 6.3

35.4 ± 7.3

36.4 ± 5.8

35.3 ± 6.3

34.1 ± 6.8

0.20

MA diameter A3c/A2c ratio

0.95 (0.83–1.06)

1.01 (0.89–1.10)

0.95 (0.85–1.07)

0.94 (0.80–1.06)

0.96 (0.80–1.07)

0.19

MAA (cm2)

9.1 ± 3.0

9.0 ± 3.5

9.9 ± 3.1

8.8 ± 2.8

8.1 ± 2.9

0.002

Moderate/severe TR [n(%)]

152 (39.2)

26 (70.3)

52 (46.0)

59 (30.9)

15 (33.3)

 < 0.001

Moderate/severe AS [n(%)]

44 (11.3)

0 (0)

18 (15.9)

21 (10.9)

5 (11.1)

0.067

Moderate/severe AR [n(%)]

42 (10.8)

2 (5.7)

9 (8.3)

20 (10.4)

11 (25.0)

0.014

Right heart

      

PASP (mmHg)

52.2 ± 17.3

56.7 ± 14.5

52.4 ± 14.1

50.9 ± 18.0

53.0 ± 24.1

0.47

  1. Bold values indicate p value < 0.05
  2. ASMR atrial functional mitral regurgitation, VSMR ventricular functional mitral regurgitation, AF atrial fibrillation, IHD ischaemic heart disease, TIA transient ischaemic attack, LVEDd left ventricular end-diastolic diameter, LVESd left ventricular end-systolic diameter, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVEF left ventricular ejection fraction, LA left atrium, MR mitral regurgitation, MA mitral annulus, A2c apical two-chamber, A3c apical three-chamber, A4c apical four-chamber, MAA mitral annulus area, TR tricuspid regurgitation, AS aortic stenosis, AR aortic regurgitation, RVSP right ventricular systolic pressure, PASP pulmonary artery systolic pressure